Abiopharma

POLYRIZON LTD. (PLRZ)

Symbol	PLRZ
Name	POLYRIZON LTD.
Sector	HEALTH CARE
Region	Middle East
Industry	Biotechnology: Pharmaceutical Preparations
Address	8 HA-PNINA STREET, RAANANA, 4321545, United States
Telephone	972-54-7979668
Fax	—
Email	—
Website	https://www.polyrizon-biotech.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001893645
Description	Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Additional info from NASDAQ: Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Our proprietary Capture and Contain, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a "biological mask" with a thin shield containment barrier in the nasal cavity. We are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs.

2026-08-20 13:30

Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment

2026-07-02 11:32

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

2026-06-29 12:44

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

2026-06-17 12:15

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

2026-06-15 12:05

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

2026-06-08 13:25

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

2026-05-13 13:25

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

2026-05-05 07:07

New Form EFFECT - Polyrizon Ltd. Filed: 2026-05-04 AccNo: 9999999995-26-001475 Size: 1 KB

2026-05-04 12:53

POLYRIZON LTD. (PLRZ) Files Form 6-K

2026-05-04 12:45

Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT07588672	Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker C…	Na	Seasonal Allergic Rhinitis (SAR)	Not_Yet_Recruiting	2026-07-15	2027-09-30	ClinicalTrials.gov

Total clinical trials: 1

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
Ayr® Saline Nasal Mist	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672
PL-14 Allergy Blocker	Other	Approved	Seasonal Allergic Rhinitis (SAR)	NOT_YET_RECRUITING	NCT07588672

Total products: 16